Sunways gets 295-kW BIPV equipment order in US from Novartis

(SeeNews) - Oct 17, 2012 - German solar firm Sunways AG (ETR:SWW) said today it had received an order to supply 295 kW of building-integrated photovoltaic (BIPV) cells to the US head office of Swiss drug maker Novartis (VTX:NOVN).

The deal includes the installation of 161,000 monocrystalline, semitransparent design solar cells on the roof of a building in East Hanover, New Jersey.

The German company did not disclose any financial details of the deal.

The worldwide market for BIPV walling is expected to surpass USD 1.5 billion (EUR 1.1bn) by 2016, market researcher NanoMarkets said in a study published at the beginning of September 2012.

(USD 1.0 = EUR 0.763)

Join Renewables Now's free daily newsletter now!

More stories to explore
Share this story
About the author
5 / 5 free articles left this month
Get 5 more for free Sign up for Basic subscription
Get full access Sign up for Premium subscription